MedPath

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Not Applicable
Recruiting
Conditions
Breast Cancer
Colorectal Cancer
Ovarian Cancer
Interventions
Behavioral: Genetic Testing and Counseling
Behavioral: Screening Form
Registration Number
NCT05649072
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.

Detailed Description

Objectives:

1. To identify underserved women at risk for hereditary breast and colorectal cancers and would be eligible for standard of care genetic counseling and testing using national screening guidelines.

2. To provide education to providers and patients regarding hereditary cancers using previously IRB approved educational material and short video.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
1000
Inclusion Criteria

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Genetic Testing and CounselingGenetic Testing and CounselingParticipants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing. The kit includes all standard paperwork and instructions for collecting the sample and shipping the kit back to the genetic testing company (Invitae).
Screening FormScreening FormParticipants will complete a screening form to assess your risk of hereditary breast and colorectal cancers.
Primary Outcome Measures
NameTimeMethod
To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines.through study completion; an average of 1 year.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

M D Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath